Fundraising Fox
HeartFlow
NASDAQ: HTFLRedwood City, US · Delaware corporation · 868 employees on LinkedIn · 10 known investors
Find your way into HeartFlow
2,632 people in our graph can introduce you to the HeartFlow team.
Sign up to see every warm intro you have to HeartFlow
- Paths you didn't know you had: your email and LinkedIn already hold routes to the HeartFlow team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Heartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD). Its platform, Heartflow One, is used by cardiologists and clinicians to guide diagnosis and treatment decisions for patients.
Founders & leadership
CA
Charles A. TaylorFounderDr. Charles A. Taylor is founder and former Chief Technology Officer (2010–2021) and Chief Scientific Officer (2021–2023) of HeartFlow, which develops AI-based analysis tools for coronary artery disease diagnosis. He holds the W.A. "Tex" Moncrief, Jr., Chair in Computational Medicine at the University of Texas at Austin and previously served as an Associate Professor in Bioengineering and Surgery at Stanford University, with expertise in computational modeling of blood flow using medical imaging data.
NE
Nicky Espinosa HayesExecutive
HB
H. Baird Radford, IIIExecutive
JF
John FarquharPresident and Chief Executive OfficerJohn Farquhar is president and CEO of HeartFlow, an AI-based platform for coronary artery disease diagnosis and management. He previously held cardiovascular and diabetes leadership roles at Medtronic and holds a bachelor's degree from Duke University and an MBA from Northwestern University's Kellogg School of Management.
Board
CT
TH
JL
Jeff LightcapBoard director
BU
Barry UphoffBoard director
Investors · 10
Bain Capital Life Scienceslisted by Bain Capital Life SciencesBoston
How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us
Blue Venture Fundslisted by Blue Venture FundsChicago · $1M – $20M
How we know: Blue Venture Funds's portfolio page · Not right? Tell us
Emergent Medical Partners, LLPlisted by Emergent Medical Partners, LLPSan Jose
How we know: Emergent Medical Partners, LLP's portfolio page · Not right? Tell us
Khosla Ventureslisted by Khosla VenturesMenlo Park · $100K – $20M
How we know: Khosla Ventures's portfolio page · Not right? Tell us
Lifeforce Capitallisted by Lifeforce CapitalChevy Chase · $500K – $5M
How we know: Lifeforce Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Silver Lake Partnerslisted by Silver Lake PartnersMenlo Park
How we know: Silver Lake Partners's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$359.6M disclosed across 4 rounds · 2011–2019
▶$65MraisedJun 2019 · 9 investors · BiotechnologyRule 506(b)
▶$65MraisedJun 2019 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dana MeadExecutive Officer, Director
- Charles A. TaylorExecutive Officer, Director
- John StevensDirector
- Casey TanseyDirector
- Lonnie SmithDirector
- William WeldonDirector
- Kent WalkerDirector
- H. Baird Radford, IIIExecutive Officer
- Noemi C. EspinosaExecutive Officer
- Jeff LightcapDirector
- Offering amount
- $100M
- Amount sold
- $65M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$90MraisedDec 2017 · 2 investors · BiotechnologyRule 506(b)
▶$90MraisedDec 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- KENT WALKERDirector
- CHARLES A. TAYLORExecutive Officer, Director
- JEFF LIGHTCAPDirector
- TOM HAWESDirector
- JOHN STEVENSExecutive Officer, Director
- LONNIE SMITHDirector
- BARRY UPHOFFDirector
- NOEMI C. ESPINOZAExecutive Officer
- CASEY TANSEYDirector
- H. BAIRD RADFORD, IIIExecutive Officer
- PHILIP M. YOUNGDirector
- CHRISTOPHER K. ZARINSExecutive Officer, Director
- WILLIAM WELDONDirector
- Offering amount
- $150M
- Amount sold
- $90M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$99.9MraisedMay 2016 · 25 investors · BiotechnologyRule 506(b)
▶$99.9MraisedMay 2016 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lonnie SmithDirector
- Christopher K. ZarinsExecutive Officer, Director
- Casey TanseyDirector
- Tom HawesDirector
- Jeff LightcapDirector
- Barry UphoffDirector
- Charles A. TaylorExecutive Officer, Director
- Nicky Espinosa HayesExecutive Officer
- William WeldonDirector
- John StevensExecutive Officer, Director
- H. Baird Radford, IIIExecutive Officer
- Philip M. YoungDirector
- Kent WalkerDirector
- Offering amount
- $110.9M
- Amount sold
- $99.9M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$104.7MraisedFeb 2014 · 29 investors · Other Health CareRule 506(b)
▶$104.7MraisedFeb 2014 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jesse Du BeyDirector
- Barry UphoffDirector
- Christopher K. ZarinsDirector
- Lonnie SmithDirector
- Thomas C. HawesDirector
- John StevensExecutive Officer, Director
- Jeff LightcapDirector
- Charles A. TaylorDirector
- Casey TanseyDirector
- Philip M. YoungDirector
- Offering amount
- $106.7M
- Amount sold
- $104.7M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through HeartFlow went on to found or lead other companies.
Related companies · 2
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
VumediVumedi operates a peer-to-peer video education platform where clinicians watch lectures and technique videos across dozens of medical specialties. It partners with academic institutions, hospitals, and life sciences companies to provide continuing medical education content to doctors.
Companies working in the same space as HeartFlow.
Frequently asked questions
- What does HeartFlow do?
- Heartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD). Its platform, Heartflow One, is used by cardiologists and clinicians to guide diagnosis and treatment decisions for patients.
- Who founded HeartFlow?
- HeartFlow was founded by Christopher K. Zarins, Charles A. Taylor.
- Who are HeartFlow's investors?
- HeartFlow's investors include 3Spoke Capital, Bain Capital Life Sciences, Blue Venture Funds, Emergent Medical Partners, LLP, Khosla Ventures, Lifeforce Capital, Lotus Capital, Silver Lake Partners and 2 more.
- How much funding has HeartFlow raised?
- HeartFlow has disclosed $359.6M raised across 4 rounds.
- Where is HeartFlow headquartered?
- HeartFlow is headquartered in Redwood City, US.